Anorectic Toxicity of Dih Ydroartemisinin,Artemether,and Arteether in Rats Following Multiple Intramuscular Doses

Abstract

During studies of arteether (AE), artemether (AM), and dihydroartemisinin (DQHS) neurotoxicity, the effect of 7 daily intramuscular doses (25, 50, and 100 mg/ kg/d) of those antimalarial drugs on gastrointestinal function was investigated in rats. A modified Nichols' method was used to measure daily food and water consumption. To estimate gastric transit, the total length amaranth (administered 40 minutes prior to sacrifice) dye traveled through small intestine were measured, and to determine gastric retention, the tied-off stomach pouch was removed and the contents weighed 24 hours after the last dose or when a rat became moribund or died. AM and AE dose solutions were prepared using sesame oil, whereas 50% dimethylacetamide (DMAC) sesame oil was used for DQHS. The results showed that after dosing with 50 mg/ kg for 7 days, 50% inhibition of food consumption (ID₅₀) occurred at 1.9 days for DQHS, 3.9 days for AM, and 4.1 days for AE. Similar data were observed for water intake. After 100 mg/kg dosing, the ID₅₀ s for food and water consumption decreased to 2.8-2.9 days for AM and 3.1-3.7 days for AE. Food consumption and body weights were decreased following all three treatments, and rats exhibited neurologic symptoms at 25-100 mg/kg dose of DQHS and 50-100 mg/kg dose of AM and AE. In addition, the results constituted a 53% and 82% inhibition of gastric transit for AM and AE, respectively, at 25 mg/kg animals compared to control, and 100% inhibition was found in high doses (50 and 100 mg/kg) for all the three drugs. The gastric retention ratio (controls equal 1.0) was 26.0 for DQHS, 5.8 with AE, and 2.3 for AM rats following 50 mg/kg dosing. When the 100 mg/kg dose was administered, the gastric retention ratio doubled for AE (11.6) and AM (4.3). The consumption data indicated that DQHS was about 2-3 times more toxic to the anorexia than AM and AE at 25 and 50 mg/kg/day dose levels. Significant differences in gastric emptying and gastric transit activities between AE and AM were observed. Data demonstrated that after multiple intramuscular doses of DQHS, AM, or AE in rats, food consumption and gastric emptying were decreased, gastric transit was inhibited, as reflected in a significant body weight reduction and death. Since an exhibition of the anorectic symptoms of AM and AE was at a lower dose than the neurologic signs in rats, the anorexia could be an early portent or prediction of the neurotoxicity in animals or humans.

Keywords

anorectic toxicity arteether artemether dihydroartemisinin food consummatory gastric retention gastric transit rat

References

Brewer, T. G. , S. J. Grate , J. O. Peggins , P. J. Weina , J. M. Petras , B. S. Levine , M. H. Heiffer and B. G. Schuster . 1994a. Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51:251–259.

Brewer, T. G. , O. J. Peggins , S. J. Grate , J. M. Petras , B. S. Levine , P. J. Weina , J. Swearengen , M. H. Heiffer and B. G. Schuster . 1994b. Neurotoxicity in animals due to arteether and artemether. Trans. R. Soc. Trop. Med. Hyg. 88(suppl. 1):S33–S36.

Brewer, T. G. , J. M. Petras , J. O. Peggins , Q.-G. Li , A. J. Lin , M. Sperry , L. Figueroa , A. Aguilar , and B. G. Schuster . 1993. Differential neurotoxicity of artemisinin analogs in an in vivo model. Am. J. Trop. Med. Hyg. 49(suppl.):292.

Bridges, J. W. , J. G. Dent and P. Johnson . 1976. The effects of some pharmacologically active amines on the rate of gastric emptying in rats. Life Sci. 18: 97–108.

Cody, R. P. , and J. K. Smith . 1987. Applied statistics and the SAS programming language. New York: North Holland Press.

Davidson, D. E. 1994. Role of arteether in the treatment of malaria and plans for further development. Trans. R. Soc. Trop. Med. Hyg. 88(suppl. 1):S51–S52.

Dunnet, C. W. 1955. A multiple comparison procedure for comparing several treatments with a control. J. Am. Statist. Assoc. 50:1096–1121.

Fishwick, J. , W. G. McLean , G. Edwards , and S. A. Ward 1995. The toxicity of artemisinin and related compounds on neuronal and glial cells in culture. Chemico-Biological Interactions 96:263–271.

Genovese, R. F. , D. B. Newman , Q.-G. Li , J. O. Peggins , and T. G. Brewer . 1997. Dose-dependent brainstem neuropathology following repeated arteether administration in rats. Brain Res. Bull. 45:100–103.

10.

Genovese, R. F. , J. M. Petras and T. G. Brewer . 1995. Arteether neurotoxicity in the absence of deficits in behavioural performance in rats. Ann. Trop. Med. Parasit. 89:447–449.

11.

Gillis, R. A. , J. A. Quest , F. D. Pagani and W P. Norman . 1989. Control centers in the central nervous system for regulating gastrointestinal motility. In Handbook of physiology, volume 1, ed. B. B. Rauner , chapter 17, Baltimore, MD: Waverly Press.

12.

Hull, K. M. , and T. J. Maher . 1990. L-Tyrosine potentiates the anorexia in duced by mixed-acting sympathomimetic drugs in hyperphagic rats. J. Pharmacol. Exp. Ther. 225:403–409.

13.

Kamchonwongpaisan, S. , P. McKeever , P. Hossler , H. Ziffer , and S. R. Meshnick . 1997. Artemisinin neurotoxicity: Neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg. 56:7–12.

14.

Kirk, R. J. 1968. Experimental design: Procedures for the behavioral sciences. Belmont, CA: Brooks/Cole Press.

15.

Li, Q.-G. , J. O. Peggins , L. L. Fleckenstein , K. Masonic , M. H. Heiffer , and T. G. Brewer . 1998. Pharmacokinetics and bioavailability of dihydroartemi-sinin, arteether, artemether, artesunic acid and artelinic acid in rats. J. Pharm. Pharmacol. 50:189–196.

16.

National Research Council (NRC) . 1996. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources Commission on Life Sciences, NRC. Washington, DC, National Academy Press.

17.

Nichols, M. B. , and R. P. Maickel . 1989. Amphetamine enantiomers and rat con-summatory behavior: A new perspective. Pharm. Biochem. Behav. 33:181–188.

18.

Parker, F. C. , D. L. Wesche and T. G. Brewer . 1994. Does iron have a role in dihydroartemisinin-induced in vitro neurotoxicity? Am. J. Trop. Med. Hyg. 51(suppl.):260.

19.

Petras, J. M. , T. G. Brewer and J. O. Peggins . 1994. Spinal cord neurotoxicity induced in Rattus rattus by the antimalarial drug arteether: A neuroanato-mical and neuropathological analysis. Anatomical. Record. 237(suppl. 1):96.

20.

Petras, J. M. , D. E. Kyle , M. Gettayacamin , G. D. Young , R. A. Bauman , H. K. Webster , K. D. Corcoran , J. O. Peggins , M. A. Vane and T. G. Brewer . 1997. Arteether: Risks of two-week administration in Macaca Mulatto. Am. J. Trop. Med. Hyg. 56:390–396.

21.

Phillips-Howard, P. A. , and F. O. Kuile . 1995. CNS adverse events associated with antimalarial agents. Drug Safety 12:370–383.

22.

Pober, Z. , D. A. Johnson , F. A. Moya-Huff , and T. J. Maher . 1989. Effect of dia-zoxide and hydralazine on intestinal transit and blood pressure in the rat. Pharmacol. Toxicol. 65:51–54.

23.

Sakata, T. , K. Fukushima , K. Tsutsui , K. Arase , and K. Fujimoto . 1982. Theo-phylline disrupts diurnal rhythms of humoral factors with loss of meal cycli-city. Physiol. Behav. 28:641–647.

24.

Tallarida, R. J. , and R. B. Murray . 1981. Manual ofpharmacologic calculations with computer programs. New York: Springer-Verlag.

25.

Wesche, D. L. , M. A. DeCoster , F. A. Tortella and T. G. Brewer . 1994. Neurotoxicity of artemisinin analogs in vitro. Antimicro. Agent Chem other. 38:1813–1819.

26.

White, N. J. 1994. Artemisinin: Current status. Trans. R. Soc. Trop. Med. Hyg. 88(suppl. 1):S3–S4.

27.

World Health Organization (WHO) . 1994. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995). WHO/MAI/94.1067. Geneva: World Health Organization.